The Egyptian Drug Authority (EDA), represented by the General Administration for Human Drug Registration, announces the publication of the first edition of the regulatory guide for Decision No. (311) of 2025 issued by the Chairman of the EDA, concerning the organization of rules and procedures for registering human medicinal products under the simulation system for export purposes.

This initiative reflects the EDA’s ongoing efforts and commitment to advancing the pharmaceutical industry and encouraging investment in the healthcare sector.

To view the regulatory guide, please click the link: